The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Molecular and Cellular Characterization of the Biological Effects of Ruthenium(II) Complexes Incorporating 2-Pyridyl-2-pyrimidine-4-carboxylic Acid
Abstract
A great majority of the Ru complexes currently studied in anticancer research exert their antiproliferative activity, at least partially, through ligand exchange. In recent years, however, coordinatively saturated and substitutionally inert polypyridyl Ru(II) compounds have emerged as potential anticancer drug candidates. In this work, we present the synthesis and detailed characterization of two novel inert Ru(II) complexes, namely, [Ru(bipy)(2)(Cpp-NH-Hex-COOH)](2+) (2) and [Ru(dppz)(2)(CppH)](2+) (3) (bipy = 2,2'-bipyridine; CppH = 2-(2'-pyridyl)pyrimidine-4-carboxylic acid; Cpp-NH-Hex-COOH = 6-(2-(pyridin-2-yl)pyrimidine-4-carboxamido)hexanoic acid; dppz = dipyrido[3,2-a:2',3'-c]phenazine). 3 is of particular interest as it was found to have IC(50) values comparable to cisplatin, a benchmark standard in the field, on three cancer cell lines and a better activity on one cisplatin-resistant cell line than cisplatin itself. The mechanism of action of 3 was then investigated in detail and it could be demonstrated that, although 3 binds to calf-thymus DNA by intercalation, the biological effects that it induces did not involve a nuclear DNA related mode of action. On the contrary, confocal microscopy colocalization studies in HeLa cells showed that 3 specifically targeted mitochondria. This was further correlated by ruthenium quantification using High-resolution atomic absorption spectrometry. Furthermore, as determined by two independent assays, 3 induced apoptosis at a relatively late stage of treatment. The generation of reactive oxygen species could be excluded as the cause of the observed cytotoxicity. It was demonstrated that the mitochondrial membrane potential in HeLa was impaired by 3 as early as 2 h after its introduction and even more with increasing time.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bradford, M. M. (1976) · Analytical Biochemistry · doi:10.1016/0003-2697(76)90527-3 · Cited by 255,302
Platinum Compounds: a New Class of Potent Antitumour Agents
ROSENBERG, B., VANCAMP, L., TROSKO, J. E., & MANSOUR, V. H. (1969) · Nature · doi:10.1038/222385a0 · Cited by 3,972
NMR Chemical Shifts of Common Laboratory Solvents as Trace Impurities
Gottlieb, H. E., Kotlyar, V., & Nudelman, A. (1997) · The Journal of Organic Chemistry · doi:10.1021/jo971176v · Cited by 3,745
Cisplatin: mode of cytotoxic action and molecular basis of resistance
Siddik, Z. H. (2003) · Oncogene · doi:10.1038/sj.onc.1206933 · Cited by 3,335
Organometallic Anticancer Compounds
Gasser, G., Ott, I., & Metzler-Nolte, N. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm100020w · Cited by 1,624
Self-citationLocalization of mitochondria in living cells with rhodamine 123.
Johnson, L. V., Walsh, M. L., & Chen, L. B. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.2.990 · Cited by 1,553
Mixed-ligand complexes of ruthenium(II): factors governing binding to DNA
Pyle, A. M., Rehmann, J. P., Meshoyrer, R., Kumar, C. V., Turro, N. J., & Barton, J. K. (1989) · Journal of the American Chemical Society · doi:10.1021/ja00190a046 · Cited by 1,463
A molecular light switch for DNA: Ru(bpy)2(dppz)2+
Friedman, A. E., Chambron, J. C., Sauvage, J. P., Turro, N. J., & Barton, J. K. (1990) · Journal of the American Chemical Society · doi:10.1021/ja00168a052 · Cited by 1,412
Ansar Ahmed, S., Gogal, R. M., & Walsh, J. E. (1994) · Journal of Immunological Methods · doi:10.1016/0022-1759(94)90396-4 · Cited by 1,359
Cisplatin: Chemistry and Biochemistry of a Leading Anticancer Drug
(1999) · Wiley eBooks · doi:10.1002/9783906390420 · Cited by 1,296
Hartinger, C. G., Jakupec, M. A., Zorbas‐Seifried, S., Groessl, M., Egger, A., Berger, W., Zorbas, H., Dyson, P. J., & Keppler, B. K. (2008) · Chemistry & Biodiversity · doi:10.1002/cbdv.200890195 · Cited by 830
Ways of dying: multiple pathways to apoptosis
Adams, J. M. (2003) · Genes & Development · doi:10.1101/gad.1126903 · Cited by 776
Metal-based antitumour drugs in the post genomic era
Dyson, P. J., & Sava, G. (2006) · Dalton Transactions · doi:10.1039/b601840h · Cited by 771
Application of d6 transition metal complexes in fluorescence cell imaging
Fernández-Moreira, V., Thorp-Greenwood, F. L., & Coogan, M. P. (2010) · Chem. Commun. · doi:10.1039/b917757d · Cited by 753
Gill, M. R., & Thomas, J. A. (2012) · Chemical Society Reviews · doi:10.1039/c2cs15299a · Cited by 747
Oscillographic polarography with periodical triangular voltage
Ševčík, A. (1948) · Collection of Czechoslovak Chemical Communications · doi:10.1135/cccc19480349 · Cited by 706
Areneruthenium complexes as anticancer agents
Süß‐Fink, G. (2009) · Dalton Transactions · doi:10.1039/b916860p · Cited by 652
The potential of organometallic complexes in medicinal chemistry
Gasser, G., & Metzler-Nolte, N. (2012) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2012.01.013 · Cited by 516
Self-citationMechanism of Coupling of Oxidative Phosphorylation and the Membrane Potential of Mitochondria
LIBERMAN, E. A., TOPALY, V. P., TSOFINA, L. M., JASAITIS, A. A., & SKULACHEV, V. P. (1969) · Nature · doi:10.1038/2221076a0 · Cited by 489
Methods to Explore Cellular Uptake of Ruthenium Complexes
Puckett, C. A., & Barton, J. K. (2007) · Journal of the American Chemical Society · doi:10.1021/ja0677564 · Cited by 467
Targeting proteins with metal complexes
Meggers, E. (2009) · Chemical Communications · doi:10.1039/b813568a · Cited by 450
Ruthenium anticancer compounds: myths and realities of the emerging metal-based drugs
Bergamo, A., & Sava, G. (2011) · Dalton Transactions · doi:10.1039/c0dt01816c · Cited by 440
Targeting the mitochondrial cell death pathway with gold compounds
Barnard, P. J., & Berners-Price, S. J. (2007) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2007.04.006 · Cited by 417
Metal based drugs: from serendipity to design
Fricker, S. P. (2007) · Dalton Transactions · doi:10.1039/b705551j · Cited by 414
Idziorek, T., Estaquier, J., De Bels, F., & Ameisen, J.-C. (1995) · Journal of Immunological Methods · doi:10.1016/0022-1759(95)00172-7 · Cited by 381
A categorization of metal anticancer compounds based on their mode of action
Gianferrara, T., Bratsos, I., & Alessio, E. (2009) · Dalton Transactions · doi:10.1039/b905798f · Cited by 336
Targeted and multifunctional arene ruthenium chemotherapeutics
Smith, G. S., & Therrien, B. (2011) · Dalton Transactions · doi:10.1039/c1dt11007a · Cited by 262
Barnard, P. J., Wedlock, L. E., Baker, M. V., Berners‐Price, S. J., Joyce, D. A., Skelton, B. W., & Steer, J. H. (2006) · Angewandte Chemie International Edition · doi:10.1002/anie.200601526 · Cited by 260
Exploring the cellular accumulation of metal complexes
Puckett, C. A., Ernst, R. J., & Barton, J. K. (2010) · Dalton Trans. · doi:10.1039/b922209j · Cited by 255
Tan, C., Lai, S., Wu, S., Hu, S., Zhou, L., Chen, Y., Wang, M., Zhu, Y., Lian, W., Peng, W., et al. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm1009296 · Cited by 244
Ruthenium Polypyridyl Complexes That Induce Mitochondria-Mediated Apoptosis in Cancer Cells
Chen, T., Liu, Y., Zheng, W.-J., Liu, J., & Wong, Y.-S. (2010) · Inorganic Chemistry · doi:10.1021/ic100277w · Cited by 241
Weiss, M. J., Wong, J. R., Ha, C. S., Bleday, R., Salem, R. R., Steele, G. D., & Chen, L. B. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.15.5444 · Cited by 240
Metal-based antitumour drugs in the post-genomic era: what comes next?
Sava, G., Bergamo, A., & Dyson, P. J. (2011) · Dalton Transactions · doi:10.1039/c1dt10522a · Cited by 231
Ruthenium Anticancer Compounds: Challenges and Expectations
Bratsos, I., Jedner, S., Gianferrara, T., & Alessio, E. (2007) · CHIMIA · doi:10.2533/chimia.2007.692 · Cited by 225
The Design of Organometallic Ruthenium Arene Anticancer Agents
Dougan, S. J., & Sadler, P. J. (2007) · CHIMIA · doi:10.2533/chimia.2007.704 · Cited by 202
Angeles-Boza, A. M., Bradley, P. M., Fu, P. K.-L., Wicke, S. E., Bacsa, J., Dunbar, K. R., & Turro, C. (2004) · Inorganic Chemistry · doi:10.1021/ic049091h · Cited by 199
Rackham, O., Nichols, S. J., Leedman, P. J., Berners-Price, S. J., & Filipovska, A. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.07.022 · Cited by 186
Schäfer, S., Ott, I., Gust, R., & Sheldrick, W. S. (2007) · European Journal of Inorganic Chemistry · doi:10.1002/ejic.200700206 · Cited by 175
Self-citationTan, C., Wu, S., Lai, S., Wang, M., Chen, Y. X., Zhou, L., Zhu, Y., Lian, W., Peng, W., Ji, L., et al. (2011) · Dalton Transactions · doi:10.1039/c1dt10084j · Cited by 105
Ruthenium(II) Metallo‐intercalators: DNA Imaging and Cytotoxicity
Gill, M. R., Derrat, H. S., Smythe, C., Battaglia, G., & Thomas, J. A. (2011) · ChemBioChem · doi:10.1002/cbic.201000782 · Cited by 101
Chiral ruthenium(II) anthraquinone complexes as dual inhibitors of topoisomerases I and II
Kou, J., Qian, C., Wang, J., Chen, X., Wang, L., Chao, H., & Ji, L. (2011) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-011-0831-6 · Cited by 100
Polypyridyl Metal Complexes with Biological Activity
Salassa, L. (2011) · European Journal of Inorganic Chemistry · doi:10.1002/ejic.201100376 · Cited by 95
Sessler, J. L., Doctrow, S. R., McMurry3, T. J., & Lippard, S. J. (2005) · ACS symposium series · doi:10.1021/bk-2005-0903 · Cited by 80
Kirin, S. I., Ott, I., Gust, R., Mier, W., Weyhermüller, T., & Metzler‐Nolte, N. (2007) · Angewandte Chemie International Edition · doi:10.1002/anie.200703994 · Cited by 79
Self-citationKilah, N. L., & Meggers, E. (2012) · Australian Journal of Chemistry · doi:10.1071/ch12275 · Cited by 69
Discovery of a strongly apoptotic ruthenium complex through combinatorial coordination chemistry
Mulcahy, S. P., Gründler, K., Frias, C., Wagner, L., Prokop, A., & Meggers, E. (2010) · Dalton Transactions · doi:10.1039/c0dt00034e · Cited by 63
Ke, H., Wang, H., Wong, W., Mak, N. K., Kwong, D. W. J., Wong, K., & Tam, H. L. (2010) · Chemical Communications · doi:10.1039/c0cc01848a · Cited by 61
Gold‐Based Therapeutic Agents: A New Perspective
Berners‐Price, S. J. (2011) · Wiley eBooks · doi:10.1002/9783527633104.ch7 · Cited by 54
Ruthenium and Other Non‐Platinum Anticancer Compounds
Bratsos, I., Gianferrara, T., Alessio, E., Hartinger, C. G., Jakupec, M. A., & Keppler, B. K. (2011) · Wiley eBooks · doi:10.1002/9783527633104.ch5 · Cited by 54
Chiral ruthenium polypyridyl complexes as mitochondria-targeted apoptosis inducers
Chen, T., Mei, W., Wong, Y.-S., Liu, J., Liu, Y., Xie, H.-S., & Zheng, W. (2010) · MedChemComm · doi:10.1039/c0md00060d · Cited by 54
Effects of the antitumoural dequalinium on NB4 and K562 human leukemia cell lines
Galeano, E., Nieto, E. O., Garcia-Perez, A. I., Delgado, M. D., Pinilla, M., & Sancho, P. (2005) · Leukemia Research · doi:10.1016/j.leukres.2005.03.014 · Cited by 51
Joshi, T., Barbante, G. J., Francis, P. S., Hogan, C. F., Bond, A. M., Gasser, G., & Spiccia, L. (2012) · Inorganic Chemistry · doi:10.1021/ic202761w · Cited by 40
Self-citationJoshi, T., Barbante, G. J., Francis, P. S., Hogan, C. F., Bond, A. M., & Spiccia, L. (2011) · Inorganic Chemistry · doi:10.1021/ic201911f · Cited by 30
Self-citationMetal Compounds as Enzyme Inhibitors
Gasser, G., & Metzler‐Nolte, N. (2011) · doi:10.1002/9783527633104.ch12 · Cited by 25
Self-citation
Cited by
Recent Strategies to Develop Innovative Photosensitizers for Enhanced Photodynamic Therapy
Pham, T. C., Nguyen, V.-N., Choi, Y., Lee, S., & Yoon, J. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00381 · Cited by 1,813
Zeng, L., Gupta, P., Chen, Y., Wang, E., Ji, L., Chao, H., & Chen, Z.-S. (2017) · Chemical Society Reviews · doi:10.1039/c7cs00195a · Cited by 1,017
Fluorescent chemical probes for accurate tumor diagnosis and targeting therapy
Gao, M., Yu, F., Lv, C., Choo, J., & Chen, L. (2017) · Chemical Society Reviews · doi:10.1039/c6cs00908e · Cited by 827
Exploration of the medical periodic table: towards new targets
Barry, N. P. E., & Sadler, P. J. (2013) · Chemical Communications · doi:10.1039/c3cc41143e · Cited by 717
Small conjugate-based theranostic agents: an encouraging approach for cancer therapy
Kumar, R., Shin, W. S., Sunwoo, K., Kim, W. Y., Koo, S., Bhuniya, S., & Kim, J. S. (2015) · Chemical Society Reviews · doi:10.1039/c5cs00224a · Cited by 381
Metadata
- Authors
- Pierroz, V., Joshi, T., Leonidova, A., Mari, C., Schur, J., Ott, I., Spiccia, L., Ferrari, S., & Gasser, G.
- Venue
- Journal of the American Chemical Society
- Publisher
- American Chemical Society (ACS)
- Published
- 2012-12-11
- Volume
- 134
- Issue
- 50
- Pages
- 20376-20387
- ISSN
- 0002-7863 (ISSN-L)
- 1520-5126
- OpenAlex
- W2080503518
- Cited by
- 296
- References
- 54
- FWCI
- 13.49
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.